tricyclic antidepressants (tca)
The "Dirty Drug"
A “dirty drug” with multiple receptor effects. Classic triad: Anticholinergic Toxidrome + Hypotension + Wide QRS. Common agents: Amitriptyline, Nortriptyline.
mechanism
The “Dirty Drug” blockade profile:
- Na-channel blockade: QRS widening, arrhythmias.
- -blockade: Hypotension (vasodilation).
- Anticholinergic: Tachycardia, delirium, hyperthermia.
- GABA antagonism: Seizures.
- Antihistamine: Sedation.
- Reuptake Inhibition: Serotonin/Norepinephrine effects.
diagnosis
- Triad: History of Ingestion + Anticholinergic Toxidrome + ECG Findings.
- Urine Tox: Not reliable for diagnosis.
- False Positives: Diphenhydramine (Benadryl), Quetiapine, Carbamazepine, Cyclobenzaprine.
clinical features
cardiovascular
- Sinus Tachycardia: Most common finding.
- QRS Widening:
- : 26% risk of seizures.
- : 50% risk of ventricular arrhythmias (VT/VF).
- Terminal R wave in aVR: Specific sign of Na-channel blockade.
cns
- LOC, Agitation, Psychosis, Delirium.
- Seizures: Can be refractory.
management
1. stabilisation & airway
- Intubation: Early for GCS < 8 or seizures.
- Hyperventilation: If intubated, maintain pH 7.50–7.55 (alkalaemia reduces drug toxicity).
2. decontamination
- Activated Charcoal: 1g/kg (max 50g).
- Indication: Ingestion within 1–2 hours.
- Contraindication: Unprotected airway (risk of aspiration with rapid LOC), ileus.
- Enhanced Elimination: No role (drug is highly protein bound and lipophilic).
3. symptom specific management
a. hypotension
- IV Fluids: Bolus 10–20 mL/kg (Saline or Sodium Bicarbonate).
- Vasopressors: Norepinephrine (preferred) or Phenylephrine (Neo-Synephrine).
- Refractory: Consider Hypertonic Saline (100 mL 3% NaCl).
b. seizures
- Benzodiazepines: First line (Lorazepam/Diazepam).
- Propofol: Second line infusion.
- Barbiturates: Third line.
contraindication: phenytoin Do NOT use Phenytoin. It blocks Na-channels and will enhance cardiotoxicity.
c. arrhythmias / qrs widening
Goal: Narrow the QRS and maintain perfusion.
- Sodium Bicarbonate (First Line):
- Indication: QRS > 100 ms, Ventricular Arrhythmia, or Hypotension.
- Bolus: 1–2 mEq/kg IV. Repeat until QRS narrows.
- Maintenance: 150 mEq (3 amps) in 1L D5W at 250 mL/hr (roughly 2x maintenance).
- Target: Serum pH 7.50–7.55. (Alkalaemia increases protein binding of TCA).
- Magnesium Sulfate: If Torsades/polymorphic VT.
- Lidocaine (Class IB): 1.5 mg/kg bolus. (Competitive binding may displace TCA).
- Lipid Emulsion: Rescue for unstable refractory arrest/shock.
- ECMO: V-A ECMO for refractory shock.
4. contraindications
- Physostigmine: Strictly contraindicated (causes asystole).
- Class IA (Procainamide) & IC (Flecainide): Worsen Na-channel blockade.
- Class III (Amiodarone): QT prolongation risk.
exam pearl
A patient with “anticholinergic toxidrome” + wide QRS is TCA until proven otherwise.